Test

Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 February 2026 – 6:30PM Fagron completes strategic acquisition of Pharmavit Europe, strengthening its...

Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth, 10.9% increase in REBITDA and 13.6% in EPS